GRACE JONES: Open Payments
NPI 1659447050 · DOTHAN, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,033 in 49 payments from 10 companies in 2025. Trend: 2023 $1,200 · 2024 $1,411 · 2025 $1,033
Food & beverage: $949Education: $84
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 29 | $457 |
| Madrigal Pharmaceuticals | 5 | $176 |
| Janssen Biotech, Inc. | 2 | $145 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 4 | $69 |
| Ipsen Biopharmaceuticals, Inc | 2 | $45 |
| Gilead Sciences, Inc. | 2 | $41 |
| Phathom Pharmaceuticals, Inc. | 2 | $37 |
| Intercept Pharmaceuticals, Inc. | 1 | $23 |
| PFIZER INC. | 1 | $20 |
| EVOKE PHARMA, INC. | 1 | $18 |
Products named: RINVOQ, REZDIFFRA, TREMFYA, SKYRIZI, XIFAXAN, LINZESS, IQIRVO, VIBERZI.
Industry payments across AL — which companies pay providers there.
